COVID-19大流行前后儿童急性鼻窦炎的时间趋势
基于儿科健康信息系统的回顾性数据库研究,分析2015至2022年42个中心2535例儿童急性鼻窦炎住院数据,比较疫情前(T1)、疫情初期(T2)和疫情后(T3)三个时段的发病率与并发症变化。结果显示T2期间急性鼻窦炎发病率下降而并发症率显著上升,T2和T3并发症率分别为37.4%和39%,均高于T1的27.5%(P < .001)。
要点
- T1、T2、T3期间急性鼻窦炎月均病例数分别为31.5例、15.8例和29例。
- T2期间10至14岁儿童急性鼻窦炎发病率最高,为32.5%。
- T2和T3并发症率分别为37.4%和39%,均显著高于T1的27.5%(P < .001)。
核心结论
- 与疫情前基线相比,COVID-19大流行初期及之后儿童急性鼻窦炎发病率同时下降而相关并发症增加,反映了疫情导致的病毒感染模式变化。
研究设计与样本
- 回顾性国家数据库审查,数据来源于儿科健康信息系统,查询2015至2022年急性鼻窦炎及相关并发症发病率数据。
- 定义三个时段:T1为COVID-19前基线,T2为大流行初期,T3为大流行后。
- 统计分析包括Wilcoxon秩和检验、多变量逻辑回归和自回归积分滑动平均(ARIMA)模型。
主要发现
- 共识别42个中心2535例急性鼻窦炎住院病例。
- 急性鼻窦炎发病率在T1为31.5例/月,T2为15.8例/月,T3为29例/月。
- T2期间10至14岁儿童急性鼻窦炎发病率最高,为32.5%。
- T1期间急性鼻窦炎与相关并发症率呈平行季节性模式。
- T2和T3并发症率分别为37.4%和39%,均显著高于T1的27.5%(P < .001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We assessed patterns in the national incidence of pediatric acute sinusitis and associated complications surrounding the initial COVID-19 lockdown. STUDY DESIGN: Retrospective National Database review. SETTING: The Pediatric Health Information System. METHODS: Acute sinusitis and associated complication incidence data from 2015 to 2022 were queried. Three time periods of T1, T2, and T3 were defined as: pre-COVID-19 baseline, initial pandemic, and postpandemic. Statistical analysis included Wilcoxon rank sum tests, multivariable logistic regressions, and autoregressive integrated moving averages (ARIMA) to assess differences between the observed complication rates in T2 and T3 and the expected incidence rates in these time periods as estimated from T1 data. RESULTS: We identified 2535 acute sinusitis admissions across 42 centers. The incidence differed between T1 (31.5 cases/month), T2 (15.8 cases/month), and T3 (29 cases/month). Children aged 10 to 14 years had the highest acute sinusitis incidence rate (32.5%) compared to other ages in T2. At T1, acute sinusitis and associated complication rates followed parallel seasonal patterns. Although sinusitis incidence decreased during T2, complications increased significantly during T2 and T3 compared to T1 (37.4% and 39% vs 27.5%, P < .001). In the ARIMA model, the ratio of the observed to expected incidence (95% confidence interval) of complications was 1.09 (0.69, 2.60) in T2 and 1.14 (0.73, 2.62) in T3. CONCLUSION: We report the simultaneous decrease in acute sinusitis incidence and an increase in associated complications during and after the initial COVID-19 pandemic compared to the prepandemic baseline, reflecting changing patterns in viral infection due to the pandemic.
引用
- Kalavacherla S, Hall M, Jiang W, et al. Temporal Trends in Pediatric Acute Sinusitis Surrounding the COVID-19 Pandemic. Otolaryngol Head Neck Surg. 2023. PMID: 37948579. doi:10.1002/ohn.578
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。